Biocartis Group NV (LTS:0R72) Change In Inventory: €-0.83 Mil (TTM As of Jun. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0R72 Biocartis Group NV LTS:0R72
14 GF Score
Price €0.30
View Full Analysis

What is Biocartis Group NV Change In Inventory?

Biocartis Group NV LTS:0R72 14 Change In Inventory is €-0.83 Mil as of Jun. 2023. GuruFocus rates LTS:0R72 with a GF Score™ of 14/100.

Biocartis Group NV's change in inventory for the quarter that ended in Jun. 2023 was €-1.05 Mil. It means Biocartis Group NV's inventory increased by €1.05 Mil from Dec. 2022 to Jun. 2023 .

Biocartis Group NV's change in inventory for the fiscal year that ended in Dec. 2022 was €-5.30 Mil. It means Biocartis Group NV's inventory increased by €5.30 Mil from Dec. 2021 to Dec. 2022 .

Biocartis Group NV's Total Inventories for the quarter that ended in Jun. 2023 was €17.88 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Biocartis Group NV's Days Inventory for the quarter that ended in Jun. 2023 was 250.93.

Inventory Turnover measures how fast the company turns over its inventory within a year. Biocartis Group NV's Inventory Turnover for the quarter that ended in Jun. 2023 was 0.73.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Biocartis Group NV's Inventory-to-Revenue for the quarter that ended in Jun. 2023 was 0.62.

Biocartis Group NV  (LTS:0R72) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Biocartis Group NV's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=18.3945/13.378*365 / 2
=250.93

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Biocartis Group NV's Inventory Turnover for the quarter that ended in Jun. 2023 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=13.378 / 18.3945
=0.73

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Biocartis Group NV's Inventory to Revenue for the quarter that ended in Jun. 2023 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=18.3945 / 29.491
=0.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biocartis Group NV Change In Inventory Related Terms

Biocartis Group NV Change In Inventory Historical Data

* Premium members only.

The historical data trend for Biocartis Group NV's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biocartis Group NV Change In Inventory Chart

Biocartis Group NV Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.86 -3.86 -4.04 -2.74 -5.30

Biocartis Group NV Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.39 0.65 -5.52 0.22 -1.05
LTS:0R72
14GF Score
Biocartis Group NV LTS:0R72
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biocartis Group NV Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.83 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of €-0.83 Mil mean?
Biocartis Group NV (LTS:0R72) has a Change In Inventory of €-0.83 Mil as of Jun. 2023. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Biocartis Group NV and its competitors.
Is Biocartis Group NV's Change In Inventory too high?
Biocartis Group NV's current Change In Inventory is €-0.83 Mil. Overall, Biocartis Group NV has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Biocartis Group NV's Change In Inventory compare to TMO and DHR?
Biocartis Group NV's Change In Inventory of €-0.83 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Medical Diagnostics & Research company?
A good Change In Inventory depends on the Medical Diagnostics & Research industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Biocartis Group NV and its competitors. Biocartis Group NV's current Change In Inventory is €-0.83 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biocartis Group NV stock overvalued right now?
Biocartis Group NV (LTS:0R72) has a current Change In Inventory of €-0.83 Mil. The current Change In Inventory is €-0.83 Mil. Biocartis Group NV's overall GF Score™ is 14/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Biocartis Group NV (LTS:0R72), the current Change In Inventory is €-0.83 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biocartis Group NV Business Description

Address Generaal de Wittelaan 11 B, Mechelen, BEL, 2800
Biocartis Group NV is a commercial-stage molecular diagnostics company. It provides diagnostic solutions aimed at improving clinical practice for patients, clinicians, payers, and the industry. The firm has developed an Meet Idylla molecular diagnostic system for oncology and infectious disease segments.
14GF Score

Get the complete analysis for LTS:0R72

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.30
Price